Global Oncology Companion Diagnostic Market Size & Outlook
Global oncology companion diagnostic market, 2018-2030 (US$M)
Related Markets
Global oncology companion diagnostic market highlights
- The global oncology companion diagnostic market generated a revenue of USD 4,781.0 million in 2023 and is expected to reach USD 8,384.0 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 8.4% by 2030.
- In terms of segment, product accounted for a revenue of USD 3,167.6 million in 2023.
- Service is the most lucrative product & service segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, China is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 4,781.0 million |
| Market revenue in 2030 | USD 8,384.0 million |
| Growth rate | 8.4% (CAGR from 2024 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Service |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Service |
Other key industry trends
- In terms of revenue, the North America accounted for 40.4% of the global oncology companion diagnostic market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, China is the fastest growing regional market and is projected to reach USD 448.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oncology Companion Diagnostic Market Scope
Oncology Companion Diagnostic Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| ARUP Laboratories | View profile | 1001-5000 | Salt Lake City, Utah, United States, North America | http://www.aruplab.com |
| Myriad Genetics Inc | View profile | 2700 | 320 Wakara Way, Salt Lake City, UT, United States, 84108 | https://www.myriad.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Global oncology companion diagnostic market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oncology companion diagnostic market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 66.25% in 2024. Horizon Databook has segmented the Global oncology companion diagnostic market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Oncology Companion Diagnostic Product & Service Outlook (Revenue, USD Million, 2018-2030)
- Product
- Instrument
- Consumables
- Software
- Service
- Product
- Global Oncology Companion Diagnostic End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospital
- Pathology/Diagnostic laboratory
- Academic medical center
- Global Oncology Companion Diagnostic Disease Type Outlook (Revenue, USD Million, 2018-2030)
- Breast cancer
- Non-small cell lung cancer
- Colorectal cancer
- Leukemia
- Melanoma
- Prostate cancer
- Others
- Global Oncology Companion Diagnostic Technology Outlook (Revenue, USD Million, 2018-2030)
- Polymerase chain reaction (PCR)
- Next-generation sequencing (NGS)
- Immunohistochemistry (IHC)
- In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
- Other technologies
Reasons to subscribe to Global oncology companion diagnostic market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global oncology companion diagnostic market databook
-
Our clientele includes a mix of oncology companion diagnostic market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global oncology companion diagnostic market , including forecasts for subscribers. This global databook contains high-level insights into Global oncology companion diagnostic market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global oncology companion diagnostics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Oncology companion diagnostics market size, 2024 (US$M)
Global oncology companion diagnostics market share, by product & service, 2024 & 2030 (%, US$M)
Oncology companion diagnostic market: Opportunity assessment by country
Global oncology companion diagnostic market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
